CXCR4 and Werner syndrome: Recently, plerixafor (or AMD3100), a small synthetic antagonist of CXCR4 approved for BM hematopoietic progenitor cells transplantation[44], has been tested in WS patients and found to promote the mobilization of neutrophils and lymphocytes to the peripheral blood[31,45].